title: Biomarkers for Parkinson's disease.
abstract: Biomarkers for detecting the early stages of Parkinson's disease (PD) could accelerate development of new treatments. Such biomarkers could be used to identify individuals at risk for developing PD, to improve early diagnosis, to track disease progression with precision, and to test the efficacy of new treatments. Although some progress has been made, there are many challenges associated with developing biomarkers for detecting PD in its earliest stages.
authors.affiliation: The Michael J. Fox Foundation for Parkinson's Research, New York, NY 10004, USA. tsherer@michaeljfox.org
authors.forename: Todd B
authors.initials: TB
authors.lastname: Sherer
mesh_terms: D015415:Biomarkers / Q000378:metabolism*; D002986:Clinical Trials as Topic; D003952:Diagnostic Imaging; D018450:Disease Progression; D006801:Humans; D010300:Parkinson Disease / Q000175:diagnosis* / Q000473:pathology / Q000503:physiopathology*
chemical_list: D015415:Biomarkers